RESEARCH TRIANGLE PARK, N.C., May 30, 2012 /PRNewswire/ -- Stiefel, a GSK (NYSE:GSK) company, and Welichem Biotech, Inc.

UNCSA to Become Exclusive Affiliate School of the Jacqueline Kennedy Onassis School at American Ballet Theatre NEW YORK, June 30, 2011 /PRNewswire-USNewswire/ -- American Ballet Theatre (ABT) and the University of North Carolina School of the Arts (UNCSA) School of Dance in Winston-Salem have announced plans for a five-year partnership, which will implement ABT's National Training Curriculum throughout the UNCSA School of Dance preparatory, high school and collegiate divisions and make UNCSA's campus a second home for ABT's Jacqueline Kennedy Onassis School by becoming an exclusive affiliate school.

RESEARCH TRIANGLE PARK, N.C., Feb. 4, 2011 /PRNewswire/ -- Stiefel, a GSK company, today announced the launch of the most-prescribed BPO Acne Wash formulations for over-the-counter (OTC) use in the United States.

LA JOLLA, Calif., July 15 /PRNewswire/ -- DermTech, Inc., a biotechnology company developing non-invasive molecular diagnostics for the early detection of disease plus additional applications, announced that it has entered into the second part of a feasibility study using DermTech's advanced EGIR(TM) technology to help Stiefel identify specific genetic markers involved in acne.

British pharmaceutical giant GlaxoSmithKline said Monday it agreed to purchase skin-products producer Stiefel Laboratories for $2.9 billion. The deal includes the assumption of $400 million of Stiefel's debt, but will add a robust development pipeline to GlaxoSmithKline's product line, the company said in a statement.